Choosing a venture
Biotechnologies, medicine, mobile applications, IT and new generations of robots and drones – what should far-sighted investors invest in?
12.11.2014Biotechnologies, medicine, mobile applications, IT and new generations of robots and drones – what should far-sighted investors invest in?
12.11.2014Russia has entered the race to create the perfect machine for organ printing: the first domestic 3D bioprinter called FABION was presented at the Open Innovations International Forum.
05.11.2014Scientists from ADG-Pharm LLC, graduates of Lomonosov Moscow State University, presented a development that can bring the treatment of alcoholism to a qualitatively new level.
05.11.2014The task – to produce 90% of medicines from the vital category in Russia by 2018 – is being solved ahead of schedule: already now we produce more than 65% of them.
05.11.2014A new anti-allergenic drug is undergoing the final stage of clinical trials. It does not just allow you to remove the symptoms of diseases, but affects their causes, which lie in the work of the immune system.
30.10.2014A device that will allow you to remove malignant tumors without surgery and general chemotherapy, and a technology that allows you to simplify and speed up the procedure of genetic analysis.
29.10.2014The national Award "Venture Investor" was established by the Russian Venture Investment Association and RVC in 2014 and is awarded to the leaders of the Russian venture industry.
16.10.2014A large-scale exposition of the latest technological achievements of Russian and foreign companies is presented at the Open Innovations Expo, which takes place within the framework of the Open Innovations Forum in Technopolis Moscow.
16.10.2014According to experts, the use of monoclonal antibodies to the PD-1 antigen will lead to a stop in tumor development in 30-40% of patients. This will be a real breakthrough in the treatment of metastatic melanoma.
03.10.2014The selection of the ten best biotech and medical startups in Russia became the final point of the cycle of events of the BiotechMed track of the federal GenerationS accelerator competition.
02.10.2014By the nature of your DNA, you can assess the risks of diseases, determine sensitivity to medications, find out personality traits, the right type of nutrition, the right sport and the place of residence of your ancestors.
02.10.2014The volume of venture financing in Russian startups fell by 9% compared to the previous year, despite the fact that in the second quarter of 2014 the number of completed transactions increased by 32%.
23.09.2014Illumina, led by Jay Flatley, single-handedly revolutionized the production of DNA sequencing devices and reduced the cost of the procedure thousands of times in 15 years. How does it manage to hold 90% of this market?
22.09.2014Academician I.F. Zhimulev: "It seems to me that it is very difficult to talk about the achievements of biology when a huge axe or shovel is brought over the whole science, with the help of which they want to bury us."
17.09.2014The organizers of the Prix Galien Russia have announced the official list of nominees for the 2014 prize.
17.09.2014HSE specialists consider the use of RNA aptamers for targeted drug delivery, implantable microchips for monitoring the treatment of chronic diseases and "pocket" biosensors for the diagnosis of acute respiratory viral infections to be the most promising trends in medicine.
12.09.2014According to research results, in 2013 Russia rose to second place in Europe and fifth in the world in terms of venture capital investments.
05.09.2014The Russian company "Genotek", founded in 2010 by graduates of Moscow State University, was one of the first in the developing Russian "genetic" market. In two and a half years from the start of sales, the company has already brought their volume to $ 1 million per year.
01.09.2014Specialists of the subsidiary of the nanocenter "Sigma.Novosibirsk" has developed a technology with the help of which it will be possible to diagnose cancer at the early stage in any polyclinic.
29.08.2014Russian scientists have come up with the Oncofinder system, which can select a drug for the treatment of a specific tumor, as well as be used to search for new drugs in the treatment of cancer. The team was supported by investors.
26.08.2014You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.